This bill, the Ensuring Compliance Against Drug Diversion Act of 2021, would terminate licenses to manufacture, distribute, or dispense controlled substances or chemicals on the Drug Enforcement Administration’s (DEA) List I, if and when the registrant dies, ceases to legally exist, discontinues business or professional practice, or surrenders their registration.
What is House Bill H.R. 1899?
Cost of House Bill H.R. 1899
In-Depth: Sponsoring Rep. Morgan Griffith (R-VA) reintroduced this legislation from the 116th Congress to limit the transfer of registrations to manufacture, distribute, or dispense controlled substances. After this bill passed the House Energy and Commerce Committee in the 116th Congress, Rep. Griffith said:
“The abuse of legal manufacturing and sales of opioids heavily contributed to the opioid crisis. The Ensuring Compliance Against Drug Diversion Act would tighten restrictions on registrations to manufacture, distribute, or dispense them, helping to reduce opioid abuse as our country continues to face this crisis.”
After this bill’s passage in the House during the previous session of Congress, Rep. Griffith further observed that “[t]he opioid crisis grew in part due to the abuse of opioids legally manufactured and sold.” He added that this legislation’s reform of Drug Enforcement Agency (DEA) regulations to close legal loopholes that could enable opioid abuse would be a “small but important fix that will assist in fighting the opioid epidemic.”
This legislation has one Republican cosponsor, Rep. Ben Cline (R-VA), in the 117th Congress.
In the previous session of Congress, Rep. Griffith introduced this bill with the support of one Republican cosponsor, Rep. Greg Walden (R-OR). It passed the House by voice vote but didn’t receive a Senate vote.
- Sponsoring Rep. Morgan Griffith (R-VA) Press Release After Committee Passage (116th Congress)
- Sponsoring Rep. Morgan Griffith (R-VA) Press Release After House Passage (116th Congress)
- CBO Cost Estimate
Summary by Lorelei Yang
(Photo Credit: iStockphoto.com / AlexanderFord)
Ensuring Compliance Against Drug Diversion Act of 2021
To amend the Controlled Substances Act to provide for the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances or list I chemicals, and for other purposes.
- Not enactedThe President has not signed this bill
- The senate has not voted
Committee on the Judiciary
- senate Committees
- The house Passed April 16th, 2021Roll Call Vote 412 Yea / 5 Nay
HealthCommittee on Energy and CommerceIntroducedMarch 16th, 2021
- house Committees